ADVFN Logo

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for charts Cadastre-se para gráficos em tempo real, ferramentas de análise e preços.

QGEN Qiagen NV

42,36
-0,39 (-0,91%)
Pré-mercado
Última atualização: 09:21:40
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Qiagen NV QGEN NYSE Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
-0,39 -0,91% 42,36 09:21:40
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
42,75
mais cotações »

Notícias Recentes

Data Hora Fonte Título
25/03/202417:05GLOBEQIAGEN introduces QIAstat-Dx Analyzer 2.0 with remote test..
18/03/202417:05GLOBEQIAGEN partners with International Panel Physicians..
11/03/202406:59GLOBEQIAGEN announces Form 20-F annual report filing for 2023..
27/02/202419:44GLOBEQIAGEN launches AI-derived biomedical knowledge base to..
27/02/202418:05GLOBEQIAGEN earns ACT Label for new eco-friendlier QIAwave..
15/02/202418:05GLOBEQIAGEN earns ACT Label for new eco-friendlier QIAwave..
06/02/202418:05GLOBEQIAGEN exceeds outlook for Q4 2023, led by 8% CER sales..
25/01/202412:00GLOBEQIAGEN announces partnership with Penn State University to..
18/01/202418:05GLOBEQIAGEN announces details for completion of synthetic share..
11/01/202409:53GLOBEQIAGEN N.V. to release results for Q4 2023 and hold webcast
08/01/202404:00GLOBEQIAGEN receives FDA clearance of NeuMoDx CT/NG Assay for use..
07/01/202415:07GLOBEQIAGEN announces plans to return approximately $300 million..
04/01/202418:05GLOBEQIAGEN to accelerate investments into QIAGEN Digital..
03/01/202404:00GLOBEQIAGEN expands business in Middle East with new regional..
30/11/202318:05GLOBEDNA Labs International solves significant cold cases with..
15/11/202318:05GLOBEQIAGEN launches TissueLyser III and RNeasy PowerMax Soil Pro..
09/11/202318:05GLOBEQIAGEN launches new QIAcuity digital PCR kits and updated..
06/11/202318:05GLOBEQIAGEN launches complete Sample to Insight workflow for..
02/11/202309:00PRNUSQIAGEN and Element Biosciences partner to offer complete..
30/10/202317:05GLOBEQIAGEN exceeds outlook for Q3 2023 with 5% CER sales growth..
26/10/202309:00GLOBEQIAGEN and Myriad Genetics partner to advance companion..
09/10/202312:14GLOBEQIAGEN N.V. to release results for Q3 2023 and hold webcast
04/10/202317:05GLOBEQIAGEN launches QuantiFERON-EBV RUO assay, facilitating..
28/09/202317:05GLOBEQIAGEN extends AI capabilities of its NGS interpretation..
27/09/202317:05GLOBEQIAGEN reports progress toward achieving Environmental,..
25/09/202317:05GLOBEQIAGEN enhances QIAwave portfolio with new eco-friendlier..
08/08/202317:05GLOBEQIAGEN delivers ahead of outlook for Q2 2023 with 9% CER..
07/08/202317:05GLOBEQIAGEN receives FDA approval for companion diagnostic to..
26/07/202317:15GLOBEBio-Rad and QIAGEN announce patent settlement and..
24/07/202308:41GLOBEQIAGEN N.V. to release results for Q2 2023 and hold webcast
18/07/202317:05GLOBEQIAGEN expands range of digital PCR kits and services for..
20/06/202317:05GLOBEFBI approves QIAGEN’s NGS-based ForenSeq MainstAY workflow..
16/06/202308:36GLOBEQIAGEN provides reminder on settlement mechanics of 2023 and..
15/06/202317:05GLOBEQIAGEN’s QuantiFERON-TB Gold Plus shows unique clinical..
13/06/202317:05GLOBEDanish National Genome Center selects QIAGEN for variant..
03/05/202317:05GLOBEQIAGEN exceeds outlook for Q1 2023 with 12% CER sales growth..
03/05/202306:30GLOBEQIAGEN welcomes U.S. Preventive Services Task Force..
24/04/202317:05GLOBEQIAGEN launches QIAstat-Dx in Japan with respiratory panel..
20/04/202317:05GLOBEQIAGEN announces expansion of Supervisory Board
14/04/202307:00GLOBEQIAGEN showcases latest technologies to advance cancer..

Seu Histórico Recente

Delayed Upgrade Clock